Document is current
Any future updates will be listed below
-
Authors
Mitropoulos, Alexandros
Boström, Carina
Mattsson, Malin
Kouidi, Evangelia
Dimitroulas, Theodoros
Liem, Sophie I. E.
Vlieland, Theodora P. M. Vliet
de Vries-Bouwstra, Jeska K.
Jacobsen, Søren
Cuomo, Giovanna
Akil, Mohammed
Klonizakis, Markos
-
Funding
Funding for this research was provided by:
Foundation for Research in Rheumatology (€ 387.216)
- License Information
-
More Information
Article History
Received: 19 September 2022
Accepted: 19 October 2022
First Online: 28 November 2022
Declarations
:
: All the patients will be requested by the local investigators to sign an informed consent before their participation in the study. The study has been approved by the appropriate local health research authorities and ethics committees relevant to the participating centres. HRA and Health and Care Research Wales (HCRW) approved the study in UK, REC reference (21/LO/0743).On the consent form, participants will be asked if they agree to use of their data should they choose to withdraw from the trial. Participants will also be asked for permission for the research team to share relevant data with people from the Universities taking part in the research or from regulatory authorities, where relevant. This trial does not involve collecting biological specimens for storage
: Not applicable.
: The authors declare that they have no competing interests.
